The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
Virtual screening of chemical libraries
Shoichet, B. K. (2004) · Nature · doi:10.1038/nature03197 · Cited by 1,425
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Schatz, A., Bugle, E., & Waksman, S. A. (1944) · Experimental Biology and Medicine · doi:10.3181/00379727-55-14461 · Cited by 1,150
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
Navigating chemical space for biology and medicine
Lipinski, C., & Hopkins, A. (2004) · Nature · doi:10.1038/nature03193 · Cited by 1,002
Integration of virtual and high-throughput screening
Bajorath, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd941 · Cited by 930
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
Fisher, J. F., Meroueh, S. O., & Mobashery, S. (2005) · Chemical Reviews · doi:10.1021/cr030102i · Cited by 913
Nonreplicating Persistence of Mycobacterium Tuberculosis
Wayne, L. G., & Sohaskey, C. D. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.139 · Cited by 807
Muñoz-Elías, E. J., & McKinney, J. D. (2005) · Nature Medicine · doi:10.1038/nm1252 · Cited by 756
Matsumoto, M., Hashizume, H., Tomishige, T., Kawasaki, M., Tsubouchi, H., Sasaki, H., Shimokawa, Y., & Komatsu, M. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030466 · Cited by 751
Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice
Cox, J. S., Chen, B., McNeil, M., & Jacobs, W. R. (1999) · Nature · doi:10.1038/47042 · Cited by 745
Structure-based maximal affinity model predicts small-molecule druggability
Cheng, A. C., Coleman, R. G., Smyth, K. T., Cao, Q., Soulard, P., Caffrey, D. R., Salzberg, A. C., & Huang, E. S. (2007) · Nature Biotechnology · doi:10.1038/nbt1273 · Cited by 695
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
Self-citationWho puts the tubercle in tuberculosis?
Russell, D. G. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1538 · Cited by 640
Camacho, L. R., Ensergueix, D., Perez, E., Gicquel, B., & Guilhot, C. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01593.x · Cited by 621
Comprehensive identification of conditionally essential genes in mycobacteria
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231275498 · Cited by 616
Self-citationThe Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism
Boshoff, H. I. M., Myers, T. G., Copp, B. R., McNeil, M. R., Wilson, M. A., & Barry, C. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406796200 · Cited by 606
Brickner, S. J., Hutchinson, D. K., Barbachyn, M. R., Manninen, P. R., Ulanowicz, D. A., Garmon, S. A., Grega, K. C., Hendges, S. K., Toops, D. S., Ford, C. W., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9509556 · Cited by 582
Diarylquinolines target subunit c of mycobacterial ATP synthase
Koul, A., Dendouga, N., Vergauwen, K., Molenberghs, B., Vranckx, L., Willebrords, R., Ristic, Z., Lill, H., Dorange, I., Guillemont, J., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio884 · Cited by 547
Innovative lead discovery strategies for tropical diseases
Nwaka, S., & Hudson, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2144 · Cited by 521
Lead discovery using molecular docking
Shoichet, B. K., McGovern, S. L., Wei, B., & Irwin, J. J. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00339-3 · Cited by 501
Antituberculosis drugs: Ten years of research
Janin, Y. L. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.030 · Cited by 485
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents
Zurenko, G. E., Yagi, B. H., Schaadt, R. D., Allison, J. W., Kilburn, J. O., Glickman, S. E., Hutchinson, D. K., Barbachyn, M. R., & Brickner, S. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.839 · Cited by 461
Tuberculosis — metabolism and respiration in the absence of growth
Boshoff, H. I. M., & Barry, C. E. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1065 · Cited by 448
Crystal Structure and Function of the Isoniazid Target of Mycobacterium tuberculosis
Dessen, A., Quémard, A., Blanchard, J. S., Jacobs, W. R., & Sacchettini, J. C. (1995) · Science · doi:10.1126/science.7886450 · Cited by 430
Self-citationTuberculosis: a problem with persistence
Stewart, G. R., Robertson, B. D., & Young, D. B. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro749 · Cited by 386
Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor
Ehrt, S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni013 · Cited by 383
Lamichhane, G., Zignol, M., Blades, N. J., Geiman, D. E., Dougherty, A., Grosset, J., Broman, K. W., & Bishai, W. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1231432100 · Cited by 357
History of the Discovery and Clinical Introduction of Chlorpromazine
López-Muñoz, F., Alamo, C., cuenca, E., Shen, W., Clervoy, P., & Rubio, G. (2005) · Annals of Clinical Psychiatry · doi:10.1080/10401230591002002 · Cited by 354
Application of fluoroquinolone pharmacodynamics
Wright, D. H. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.5.669 · Cited by 342
Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials
Burman, W. J., Gallicano, K., & Peloquin, C. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140050-00002 · Cited by 337
Manjunatha, U. H., Boshoff, H., Dowd, C. S., Zhang, L., Albert, T. J., Norton, J. E., Daniels, L., Dick, T., Pang, S. S., & Barry, C. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508392103 · Cited by 331
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid
Vilchèze, C., Wang, F., Arai, M., Hazbón, M. H., Colangeli, R., Kremer, L., Weisbrod, T. R., Alland, D., Sacchettini, J. C., & Jacobs, W. R. (2006) · Nature Medicine · doi:10.1038/nm1466 · Cited by 319
Self-citationMechanism of thioamide drug action against tuberculosis and leprosy
Wang, F., Langley, R., Gulten, G., Dover, L. G., Besra, G. S., Jacobs, W. R., & Sacchettini, J. C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062100 · Cited by 303
Self-citationMetronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis
Wayne, L. G., & Sramek, H. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2054 · Cited by 295
Rozwarski, D. A., Vilchèze, C., Sugantino, M., Bittman, R., & Sacchettini, J. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15582 · Cited by 290
Self-citationInhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs
Weinstein, E. A., Yano, T., Li, L.-S., Avarbock, D., Avarbock, A., Helm, D., McColm, A. A., Duncan, K., Lonsdale, J. T., & Rubin, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500469102 · Cited by 289
Challenges in tuberculosis drug research and development
Ginsberg, A. M., & Spigelman, M. (2007) · Nature Medicine · doi:10.1038/nm0307-290 · Cited by 283
Targeting Tuberculosis and Malaria through Inhibition of Enoyl Reductase
Kuo, M. R., Morbidoni, H. R., Alland, D., Sneddon, S. F., Gourlie, B. B., Staveski, M. M., Leonard, M., Gregory, J. S., Janjigian, A. D., Yee, C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211968200 · Cited by 263
Self-citationStructure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis.
Sharma, V., Sharma, S., zu Bentrup, K. H., McKinney, J. D., Russell, D. G., Jacobs, W. R., & Sacchettini, J. C. (2000) · Nature Structural Biology · doi:10.1038/77964 · Cited by 255
Self-citationSchatz, A., & Waksman, S. A. (1944) · Experimental Biology and Medicine · doi:10.3181/00379727-57-14769 · Cited by 251
Sullivan, T. J., Truglio, J. J., Boyne, M. E., Novichenok, P., Zhang, X., Stratton, C. F., Li, H.-J., Kaur, T., Amin, A., Johnson, F., et al. (2006) · ACS Chemical Biology · doi:10.1021/cb0500042 · Cited by 236
Pharmacodynamics and pharmacokinetics of SQ109, a new diamine‐based antitubercular drug
Jia, L., Tomaszewski, J. E., Hanrahan, C., Coward, L., Noker, P., Gorman, G., Nikonenko, B., & Protopopova, M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705984 · Cited by 231
Linezolid for the treatment of multidrug-resistant tuberculosis
Fortún, J., Martín-Dávila, P., Navas, E., Pérez-Elías, M. J., Cobo, J., Tato, M., De la Pedrosa, E. G.-G., Gómez-Mampaso, E., & Moreno, S. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki148 · Cited by 225
Flores, A. R., Parsons, L. M., & Pavelka (2005) · Microbiology · doi:10.1099/mic.0.27629-0 · Cited by 217
Treatment of HIV-related Tuberculosis in the Era of Effective Antiretroviral Therapy
BURMAN, W. J., & JONES, B. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.1.2101133 · Cited by 214
Lee, R. E., Protopopova, M., Crooks, E., Slayden, R. A., Terrot, M., & Barry, C. E. (2003) · Journal of Combinatorial Chemistry · doi:10.1021/cc020071p · Cited by 207
Ordway, D., Viveiros, M., Leandro, C., Bettencourt, R., Almeida, J., Martins, M., Kristiansen, J. E., Molnar, J., & Amaral, L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.917-922.2003 · Cited by 200
Takiff, H. E., Cimino, M., Musso, M. C., Weisbrod, T., Martinez, R., Delgado, M. B., Salazar, L., Bloom, B. R., & Jacobs, W. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.362 · Cited by 198
The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis
Parish, T., & Stoker, N. G. (2002) · Microbiology · doi:10.1099/00221287-148-10-3069 · Cited by 198
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
Chambers, H. F., Moreau, D., Yajko, D., Miick, C., Wagner, C., Hackbarth, C., Kocagöz, S., Rosenberg, E., Hadley, W. K., & Nikaido, H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2620 · Cited by 197
Aubry, A., Veziris, N., Cambau, E., Truffot-Pernot, C., Jarlier, V., & Fisher, L. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.104-112.2006 · Cited by 197
Tetracycline-inducible gene regulation in mycobacteria
Blokpoel, M. C. J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni023 · Cited by 189
Rengarajan, J., Sassetti, C. M., Naroditskaya, V., Sloutsky, A., Bloom, B. R., & Rubin, E. J. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04120.x · Cited by 174
Self-citationTwo decades of imipenem therapy
Rodloff, A. C., Goldstein, E. J. C., & Torres, A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl354 · Cited by 171
New Tuberculosis Therapeutics: A Growing Pipeline
Spigelman, M. K. (2007) · The Journal of Infectious Diseases · doi:10.1086/518663 · Cited by 169
Alland, D., Steyn, A. J., Weisbrod, T., Aldrich, K., & Jacobs, W. R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.7.1802-1811.2000 · Cited by 165
Park, I.-N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl298 · Cited by 161
Deidda, D., Lampis, G., Fioravanti, R., Biava, M., Porretta, G. C., Zanetti, S., & Pompei, R. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.3035 · Cited by 159
Wang, F., Cassidy, C., & Sacchettini, J. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00320-06 · Cited by 154
Self-citationGenetic Basis for Natural and Acquired Resistance to the Diarylquinoline R207910 in Mycobacteria
Petrella, S., Cambau, E., Chauffour, A., Andries, K., Jarlier, V., & Sougakoff, W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00244-06 · Cited by 147
Activity of Amoxicillin/Clavulanate in Patients with Tuberculosis
Chambers, H. F. “., Kocagöz, T., Şipit, T., Turner, J., & Hopewell, P. C. (1998) · Clinical Infectious Diseases · doi:10.1086/513945 · Cited by 146
Amaral, L., Kristiansen, J. E., Viveiros, M., & Atouguia, J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.505 · Cited by 144
Lounis, N., Véziris, N., Chauffour, A., Truffot-Pernot, C., Andries, K., & Jarlier, V. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00766-06 · Cited by 143
Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)—a report of ten cases
von der Lippe, B., Sandven, P., & Brubakk, O. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.04.007 · Cited by 142
Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics
Colca, J. R., McDonald, W. G., Waldon, D. J., Thomasco, L. M., Gadwood, R. C., Lund, E. T., Cavey, G. S., Mathews, W. R., Adams, L. D., Cecil, E. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302109200 · Cited by 139
Amaral, L., Kristiansen, J. E., Abebe, L. S., & Millett, W. P. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.6.1049 · Cited by 138
Differential Antibiotic Susceptibilities of Starved Mycobacterium tuberculosis Isolates
Xie, Z., Siddiqi, N., & Rubin, E. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4778-4780.2005 · Cited by 136
Self-citationMycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid
Argyrou, A., Vetting, M. W., Aladegbami, B. G., & Blanchard, J. S. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1089 · Cited by 131
Chlorpromazine: A Drug Potentially Useful for Treating Mycobacterial Infections
Crowle, A. J., Douvas, G. S., & May, M. H. (2009) · Chemotherapy · doi:10.1159/000239036 · Cited by 128
Imipenem for Treatment of Tuberculosis in Mice and Humans
Chambers, H. F. “., Turner, J., Schecter, G. F., Kawamura, M., & Hopewell, P. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2816-2821.2005 · Cited by 114
Lin, T., Melgar, M. M., Kurth, D. G., Swamidass, S. J., Purdon, J., Teresa, T., Gago, G., Baldi, P., Gramajo, H. C., & Tsai, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510580103 · Cited by 113
Metronidazole Therapy in Mice Infected with Tuberculosis
Brooks, J. V., Furney, S. K., & Orme, I. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1285 · Cited by 92
Carroll, P., Muttucumaru, D. G. N., & Parish, T. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.6.3077-3084.2005 · Cited by 90
Bémer-Melchior, P., Bryskier, A., & Drugeon, H. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.4.571 · Cited by 85
Proteome-wide Profiling of Isoniazid Targets in Mycobacterium tuberculosis
Argyrou, A., Jin, L., Siconolfi-Baez, L., Angeletti, R. H., & Blanchard, J. S. (2006) · Biochemistry · doi:10.1021/bi061874m · Cited by 81
Mechanism of antimicrobial action of metronidazole
Edwards, D. I. (1979) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/5.5.499 · Cited by 81
Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative.
Arioli, V., BERTI, M., CARNITI, G., Randisi, E., Rossi, E., & SCOTTI, R. (1981) · The Journal of Antibiotics · doi:10.7164/antibiotics.34.1026 · Cited by 77
A Novel Inhibitor of Mycobacterium tuberculosis Pantothenate Synthetase
White, E. L., Southworth, K., Ross, L. J., Cooley, S., Gill, R. B., Sosa, M. I., Manouvakhova, A., Rasmussen, L. A., Goulding, C. W., Eisenberg, D. S., et al. (2006) · SLAS DISCOVERY · doi:10.1177/1087057106296484 · Cited by 68
Madrid, P. B., Polgar, W. E., Toll, L., & Tanga, M. J. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.03.064 · Cited by 66
Flores, A. R., Parsons, L. M., & Pavelka, M. S. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.6.1892-1900.2005 · Cited by 64
Hirata, T., Saito, H., Tomioka, H., Sato, K., Jidoi, J., Hosoe, K., & HIDAKA, T. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2295 · Cited by 60
Nopponpunth, V., Sirawaraporn, W., Greene, P. J., & Santi, D. V. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.21.6814-6821.1999 · Cited by 59
Biosynthesis of C30 to C56 fatty acids by an extract of Mycobacterium tuberculosis H37Ra
Qureshi, N., Sathyamoorthy, N., & Takayama, K. (1984) · Journal of Bacteriology · doi:10.1128/jb.157.1.46-52.1984 · Cited by 55
Synthesis and antitubercular activity of quaternized promazine and promethazine derivatives
Bate, A. B., Kalin, J. H., Fooksman, E. M., Amorose, E. L., Price, C. M., Williams, H., Rodig, M. J., Mitchell, M. O., Cho, S., Wang, Y., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.11.091 · Cited by 48
Manetti, F., Magnani, M., Castagnolo, D., Passalacqua, L., Botta, M., Corelli, F., Saddi, M., Deidda, D., & Logu, A. D. (2006) · ChemMedChem · doi:10.1002/cmdc.200600026 · Cited by 47
Streptomycin, Schatz v. Waksman, and the Balance of Credit for Discovery
Kingston, W. (2004) · Journal of the History of Medicine and Allied Sciences · doi:10.1093/jhmas/jrh091 · Cited by 42
Antitubercular activity of trifluoperazine, a calmodulin antagonist
Ratnakar, P., & Murthy, P. S. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05442.x · Cited by 39
Mycobacterium tuberculosisの必須アシル‐CoAカルボキシラーゼカルボキシルトランスフェラーゼドメインAccD5の構造依存阻害剤デザイン
Ting‐Wan, L., Melgar, M. M., Daniel, K., Joshua, S. S., John, P. H., Teresa, T., Gago, G., Baldi, P., Gramajo, H. C., & Tsai, S. (2006) · Cited by 34
Chlorpromazine in nonpsychotic patients with pulmonary tuberculosis.
Hollister, L. E., EIKENBERRY, D. T., & Raffel, S. (1960) · PubMed · doi:10.1164/arrd.1960.81.4.562 · Cited by 29
In-vitro and intracellular antimycobacterial activity of trifluoperazine
REDDY, M. V., Nadadhur, G., & Gangadharam, P. R. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.1.196 · Cited by 20
Sauvage, E., Fonzé, E., Quinting, B., Galleni, M., Frère, J., & Charlier, P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01226-05 · Cited by 20
Cited by
From Vaccines to Memory and Back
Sallusto, F., Lanzavecchia, A., Araki, K., & Ahmed, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.008 · Cited by 637
Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
Adams, K. N., Takaki, K., Connolly, L. E., Wiedenhoft, H., Winglee, K., Humbert, O., Edelstein, P. H., Cosma, C. L., & Ramakrishnan, L. (2011) · Cell · doi:10.1016/j.cell.2011.02.022 · Cited by 530
Gavrish, E., Sit, C. S., Cao, S., Kandror, O., Spoering, A., Peoples, A., Ling, L., Fetterman, A., Hughes, D., Bissell, A., et al. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.01.014 · Cited by 423
The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
Dartois, V. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3200 · Cited by 388
Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis
Harbut, M. B., Vilchèze, C., Luo, X., Hensler, M. E., Guo, H., Yang, B., Chatterjee, A. K., Nizet, V., Jacobs, W. R., Schultz, P. G., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504022112 · Cited by 330
Metadata
- Authors
- Sacchettini, J. C., Rubin, E. J., & Freundlich, J. S.
- Venue
- Nature Reviews Microbiology
- Published
- 2008-01
- Volume
- 6
- Issue
- 1
- Pages
- 41-52
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2041298534
- Cited by
- 256
- References
- 99
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.